24 Jan2014
2 Alzheimer’s Drugs Found Ineffective in Clinical Trials
Dashing hopes, bapineuzumab and solanezumab did not improve patients’ ability to think or perform daily activities
By Dennis Thompson
HealthDay Reporter
WEDNESDAY, Jan. 22, 2014 (HealthDay News) — Two experimental drugs for Alzheimer’s disease have failed their clinical trials, proving unable to help patients with mild to moderate dementia, according to new studies.